{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:26:48Z","timestamp":1774038408012,"version":"3.50.1"},"reference-count":151,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1053\/j.jvca.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T02:41:51Z","timestamp":1657766511000},"page":"4161-4172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preoperative Evaluation and Care of Heart Transplant Candidates"],"prefix":"10.1053","volume":"36","author":[{"given":"Nian Chih","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumaraswamy","family":"Sivathasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2022.07.008_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0002","first-page":"549","article-title":"Long-term outcome following heart transplantation: Current perspective","volume":"7","author":"Wilhelm","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.jvca.2022.07.008_bib0003","first-page":"1120","article-title":"Adult heart transplant: Indications and outcomes","volume":"6","author":"Alraies","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.jvca.2022.07.008_bib0004","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty sixth adult heart transplantation report \u2014 2019; focus theme: Donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation (ISHLT): Thirty-fifth Adult Heart and Lung Transplantation Report \u2014 2018; focus theme: Multiorgan transplantation","volume":"30","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0006","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jtcvs.2020.08.113","article-title":"The new heart transplant allocation system: Early observations and mechanical circulatory support considerations","volume":"161","author":"Estep","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0007","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.healun.2016.08.008","article-title":"Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-an analysis of the International Society for Heart and Lung Transplantation Registry","volume":"36","author":"Wever-Pinzon","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011124","article-title":"Human leukocyte antigen-based risk stratification in heart transplant recipients - implications for targeted surveillance","volume":"8","author":"Nilsson","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2022.07.008_bib0009","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/ijms20184544","article-title":"The role of major histocompatibility complex in organ transplantation- donor specific anti-major histocompatibility complex antibodies analysis goes to the next stage","volume":"20","author":"Nakamura","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.jvca.2022.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2017.05.025","article-title":"Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation","volume":"36","author":"Wright","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.healun.2016.07.009","article-title":"Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality","volume":"36","author":"Cooper","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0012","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report\u20132015; focus theme: Early Graft Failure","volume":"34","author":"Lund","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0013","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jamadermatol.2018.4789","article-title":"Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients","volume":"155","author":"De Rosa","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/dsu.12028","article-title":"Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: A review of single- and multicenter retrospective studies from 2006 to 2010","volume":"39","author":"Mudigonda","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2012.09.030","article-title":"Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation","volume":"68","author":"Gogia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0016","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0018","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0019","first-page":"229","article-title":"Donor-specific HLA alloantibodies: Long-term impact on cardiac allograft vasculopathy and mortality after heart transplant","volume":"6","author":"Kaczmarek","year":"2008","journal-title":"Exp Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system: First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA system. Second of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0022","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/204998b0","article-title":"Microdroplet assay of human serum cytotoxins","volume":"204","author":"Terasaki","year":"1964","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2022.07.008_bib0023","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1161\/CIR.0000000000000598","article-title":"Sensitization in heart transplantation: Emerging knowledge: A scientific statement from the American Heart Association","volume":"139","author":"Colvin","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0024","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.humimm.2003.12.007","article-title":"Unappreciated risk factors for transplant patients: HLA antibodies in blood components","volume":"65","author":"Bray","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0198-8859(02)00441-X","article-title":"A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts","volume":"63","author":"Welters","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/circ.104.suppl_1.I-177","article-title":"Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients","volume":"104","author":"Lietz","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0027","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-0012.2010.01259.x","article-title":"Management of the sensitized adult heart transplant candidate","volume":"24","author":"Eckman","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0028","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MAT.0b013e31826d6070","article-title":"Alloimmunosensitization in left ventricular assist device recipients and impact on post transplantation outcome","volume":"58","author":"Urban","year":"2012","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejcts.2006.07.022","article-title":"The role of leukocyte depleting filters in heart transplantation: Early outcomes in prospective, randomized clinical trial","volume":"30","author":"Dvorak","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0031","first-page":"876","article-title":"Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support","volume":"17","author":"Moazami","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0032","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1600-6143.2006.01342.x","article-title":"Sensitization following LVAD implantation using leucodepleted blood is not due to HLA antibodies","volume":"6","author":"Newell","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0033","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jtcvs.2006.11.062","article-title":"Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions","volume":"133","author":"Drakos","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0034","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2016.05.019","article-title":"Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure","volume":"35","author":"Netuka","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.healun.2019.05.006","article-title":"Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial","volume":"38","author":"Bansal","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0036","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2018.03.002","article-title":"Evaluation of low-intensity anticoagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study","volume":"37","author":"Netuka","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0037","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jtcvs.2007.11.049","article-title":"Association of device surface and biomaterials with immunologic sensitization after mechanical support","volume":"135","author":"George","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0038","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0003-4975(03)00480-6","article-title":"Interactions between the recipient immune system and the left ventricular assist device surface: Immunological and clinical implications","volume":"75","author":"Itescu","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0039","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0198-8859(01)00380-9","article-title":"B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression","volume":"63","author":"Schuster","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1053-2498(01)00232-7","article-title":"Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival","volume":"20","author":"Pagani","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0041","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.healun.2013.08.014","article-title":"HLA and MICA allosensitization patterns among patients supported by ventricular assist devices","volume":"32","author":"Askar","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0042","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jtcvs.2015.01.003","article-title":"Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart transplantation patient","volume":"149","author":"Kwon","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0043","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.healun.2017.03.018","article-title":"Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation","volume":"36","author":"See","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0044","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MAT.0000000000000388","article-title":"Design rationale and preclinical evaluation of the HeartMate 3 left ventricular assist system for hemocompatibility","volume":"62","author":"Bourque","year":"2016","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0045","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long-term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0046","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0047","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0048","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0049","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199403243301203","article-title":"The influence of HLA compatibility on graft survival after heart transplantation","volume":"330","author":"Opelz","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.healun.2018.01.1291","article-title":"The management of antibodies in heart transplantation: An ISHLT consensus document","volume":"37","author":"Kobashigawa","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0051","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-199210000-00017","article-title":"Outcome of cardiac transplant recipients with a positive donor-specific crossmatch\u2013preliminary results with plasmapheresis","volume":"54","author":"Ratkovec","year":"1992","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0052","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trre.2008.08.004","article-title":"Antibody-mediated rejection: Treatment alternatives and outcomes","volume":"23","author":"Singh","year":"2009","journal-title":"Transplant Rev"},{"key":"10.1053\/j.jvca.2022.07.008_bib0053","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0054","doi-asserted-by":"crossref","first-page":"II229","DOI":"10.1161\/circ.100.suppl_2.Ii-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0055","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1067\/mai.2001.117824","article-title":"Antibody-directed therapy: Past, present, and future","volume":"108","author":"Gelfand","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0056","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","article-title":"Manipulating the immune system with immune globulin","volume":"326","author":"Dwyer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0057","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MOT.0b013e328330f304","article-title":"Proteasome inhibition for antibody-mediated rejection","volume":"14","author":"Everly","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0058","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0059","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids - new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0060","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.healun.2008.06.004","article-title":"Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: A strategy to shorten left ventricular assist device support","volume":"27","author":"Lick","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0061","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.healun.2015.01.073","article-title":"Terminal complement inhibition for highly sensitized patients undergoing heart transplantation: Doable?","volume":"34","author":"Patel","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0062","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIR.0000000000000093","article-title":"Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: A scientific statement from the American Heart Association","volume":"131","author":"Colvin","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0063","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0064","doi-asserted-by":"crossref","first-page":"e13621","DOI":"10.1111\/ctr.13621","article-title":"The effect of pre\u2013heart transplant body mass index on posttransplant outcomes: An analysis of the ISHLT Registry Data","volume":"33","author":"Doumouras","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5694\/j.1326-5377.2007.tb00935.x","article-title":"Obesity and early complications after cardiac surgery","volume":"186","author":"Ch","year":"2007","journal-title":"Med J Aust"},{"key":"10.1053\/j.jvca.2022.07.008_bib0066","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jhin.2014.06.011","article-title":"Risk factors for mediastinitis following cardiac surgery: The importance of managing obesity","volume":"88","author":"Rehman","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1053\/j.jvca.2022.07.008_bib0067","doi-asserted-by":"crossref","first-page":"e93992","DOI":"10.1371\/journal.pone.0093992","article-title":"Post-operative hypoxia and length of intensive care unit stay after cardiac surgery: The underweight paradox?","volume":"9","author":"Ranucci","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2022.07.008_bib0068","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1053\/j.jvca.2019.09.019","article-title":"Deep sternal wound infection: Diagnosis, treatment and prevention","volume":"34","author":"Phoon","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0069","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/dom.14207","article-title":"Imperial satiety protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesity","volume":"23","author":"Hameed","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1053\/j.jvca.2022.07.008_bib0070","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ehf2.13213","article-title":"High-protein vs. standard-protein diets in overweight and obese patients with heart failure and diabetes mellitus: Findings of the Pro-HEART trial","volume":"8","author":"Evangelista","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0071","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1161\/CIR.0b013e3182149099","article-title":"Bariatric surgery and cardiovascular risk factors: Aa scientific statement from the American Heart Association","volume":"123","author":"Poirier","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0072","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.transproceed.2012.10.036","article-title":"Bariatric surgery in severe obesity and end-stage heart failure with mechanical circulatory support as a bridge to successful heart transplantation: A case report","volume":"45","author":"Caceres","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1053\/j.jvca.2022.07.008_bib0073","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cardfail.2020.12.011","article-title":"Bariatric surgery in patients with obesity and ventricular assist devices considered for heart transplantation: Systematic review and individual participant data meta-analysis","volume":"27","author":"daSilva-deAbreu","year":"2021","journal-title":"J Card Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0074","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11695-015-1789-1","article-title":"Bariatric surgery provides a \"bridge to transplant\" for morbidly obese patients with advanced heart failure and may obviate the need for transplantation","volume":"26","author":"Lim","year":"2016","journal-title":"Obes Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/SLA.0b013e3181b5db3c","article-title":"The effect of body mass index on survival following heart transplantation: Do outcomes support consensus guidelines?","volume":"251","author":"Russo","year":"2010","journal-title":"Ann Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0076","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12630-014-0302-y","article-title":"Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: A historical multicentre cohort study","volume":"62","author":"Karkouti","year":"2015","journal-title":"Can J Anaesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0077","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.jvca.2018.08.003","article-title":"Acute kidney injury after cardiac surgery: A narrative review of the literature","volume":"33","author":"Chew","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0078","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0002-9149(89)90256-7","article-title":"Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"63","author":"Carr","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0079","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2008.03.007","article-title":"Nutritional and anti-inflammatory interventions in chronic heart failure","volume":"101","author":"Kalantar-Zadeh","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0081","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0000000000000991","article-title":"The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation","volume":"100","author":"Jha","year":"2016","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0082","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1053\/j.jvca.2018.08.002","article-title":"Frailty in the end-stage lung disease or heart failure patient: Implications for the perioperative transplant clinician","volume":"33","author":"Bottiger","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0083","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult heart transplantation report\u20142016; focus theme: Primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0084","doi-asserted-by":"crossref","first-page":"e9629","DOI":"10.1097\/MD.0000000000009629","article-title":"Home-based cardiac rehabilitation improves quality of life, aerobic capacity, and readmission rates in patients with chronic heart failure","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.jvca.2022.07.008_bib0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/2047487317750427","article-title":"The prognostic significance of improvement in exercise capacity in heart failure patients who participate in cardiac rehabilitation programme","volume":"25","author":"Sabbag","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0086","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijcard.2016.10.026","article-title":"Exercise training effects on elderly and middle-age patients with chronic heart failure after acute decompensation: A randomized, controlled trial","volume":"225","author":"Acanfora","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0087","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2016.01.207","article-title":"The influence of training characteristics on the effect of aerobic exercise training in patients with chronic heart failure: A meta-regression analysis","volume":"208","author":"Vromen","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0088","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1177\/2047487319889709","article-title":"Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list","volume":"27","author":"Gimeno-Santos","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0089","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1053\/j.jvca.2019.07.091","article-title":"Multimodal prehabilitation: A promising strategy in patients listed for heart transplantation","volume":"33","author":"Arguis","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.endonu.2013.01.013","article-title":"Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism","volume":"60","author":"Curotto Grasiosi","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1053\/j.jvca.2022.07.008_bib0091","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/pmj.76.893.133","article-title":"Amiodarone-induced thyroid disorders: A clinical review","volume":"76","author":"Loh","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0092","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","article-title":"Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation","volume":"90","author":"Lau","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0093","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: A scientific statement from the American Heart Association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0094","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0096","series-title":"StatPearls","article-title":"Cardiac Cirrhosis","author":"Rodriguez Ziccardi","year":"2022"},{"key":"10.1053\/j.jvca.2022.07.008_bib0097","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0098","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"CHARM Investigators. Liver function abnormalities and outcome in patients with chronic heart failure: Data from the Candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0099","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2013.02.064","article-title":"The MELD scoring system and the prediction of outcomes in heart failure patients: What we have learned from the hepatologists","volume":"61","author":"Eisen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MAT.0b013e31827c0c77","article-title":"Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation","volume":"59","author":"Deo","year":"2013","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.109.872556","article-title":"Clinical predictors of hepatic fibrosis in chronic advanced heart failure","volume":"3","author":"Gelow","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0102","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ehf2.13118","article-title":"Congestive nephropathy: A neglected entity? Proposal for diagnostic criteria and future perspectives","volume":"8","author":"Husain-Syed","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/erc.11.102","article-title":"The challenge of treating congestion in advanced heart failure","volume":"9","author":"Bonios","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1053\/j.jvca.2022.07.008_bib0106","article-title":"Cardiorenal syndrome in heart failure: A cardiologist's perspective","volume":"24","author":"Liu","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0107","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.ajkd.2006.08.002","article-title":"Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation","volume":"48","author":"Boyle","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jvca.2022.07.008_bib0108","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0109","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.acvd.2014.07.049","article-title":"Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists","volume":"107","author":"Cohen-Solal","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1053\/j.jvca.2022.07.008_bib0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ejhf.820","article-title":"Iron deficiency and red cell indices in patients with heart failure","volume":"20","author":"Tkaczyszyn","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0111","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: An international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0112","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0113","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: Prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0114","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCHEARTFAILURE.111.960906","article-title":"Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: Prevalence and associations with anemia and inflammation","volume":"4","author":"Parikh","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0115","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ejhf.161","article-title":"Iron deficiency in a multi-ethnic Asian population with and without heart failure: Prevalence, clinical correlates, functional significance and prognosis","volume":"16","author":"Yeo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0116","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0117","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: Intravenous or oral?","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0119","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/131.2.568S","article-title":"Iron biology in immune function, muscle metabolism and neuronal functioning","volume":"131","author":"Beard","year":"2001","journal-title":"J Nutr"},{"key":"10.1053\/j.jvca.2022.07.008_bib0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","article-title":"Iron status in chronic heart failure: Impact on symptoms, functional class and submaximal exercise capacity","volume":"69","author":"Enjuanes","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1053\/j.jvca.2022.07.008_bib0122","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","article-title":"Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status","volume":"15","author":"Comin-Colet","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: Results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0124","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ejhf.513","article-title":"Iron deficiency and risk of early readmission following a hospitalization for acute heart failure","volume":"18","author":"Nunez","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0125","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: An ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. FERRIC-HF: A randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0127","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2022.07.008_bib0128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2022.07.008_bib0129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: A meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: An individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2022.07.008_bib0132","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: A meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0133","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2022.07.008_bib0134","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2022.07.008_bib0135","unstructured":"Vifor Pharma Ltd. Ferinject (ferric carboxymaltose). Summary of Product Characteristics. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/5910\/smpc#gref. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0136","unstructured":"Ahmed T, Jain A. Heart transplantation. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557571\/. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0137","doi-asserted-by":"crossref","first-page":"e13816","DOI":"10.1111\/ctr.13816","article-title":"Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience","volume":"34","author":"Nayak","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0138","unstructured":"Organ Procurement & Transplantation Network. Criteria requirements in adult heart allocation policy. Available at: https:\/\/optn.transplant.hrsa.gov\/media\/2413\/adult_heart_criteria.pdf. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0139","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ajt.15816","article-title":"New French heart allocation system: Comparison with Eurotransplant and US allocation systems","volume":"20","author":"Dorent","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0140","unstructured":"United Network for Organ Sharing. Talking about Transplantation. Questions and answers for transplant candidates about heart allocation for adult candidates. Available at: https:\/\/unos.org\/wp-content\/uploads\/unos\/UNOS-110_heart.pdf. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0141","unstructured":"Organ Procurement & Transplantation Network. Continuous distribution. Available at: https:\/\/optn.transplant.hrsa.gov\/governance\/key-initiatives\/continuous-distribution\/. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0142","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/TP.0000000000001724","article-title":"Prediction of waitlist mortality in adult heart transplant candidates: The Candidate Risk Score","volume":"101","author":"Jasseron","year":"2017","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0143","unstructured":"National Health Service. POL228\/12 \u2013 Heart transplantation: Organ allocation. Available at: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/24240\/pol228-12.pdf. Accessed January 23, 2022."},{"key":"10.1053\/j.jvca.2022.07.008_bib0144","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.healun.2018.09.017","article-title":"Predicted heart mass is the optimal metric for size match in heart transplantation","volume":"38","author":"Kransdorf","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0145","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1111\/ctr.14192","article-title":"Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?","volume":"35","author":"Cheshire","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2022.07.008_bib0146","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","article-title":"The relationship of left ventricular mass and geometry to incident cardiovascular events: The MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"52","author":"Bluemke","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2022.07.008_bib0147","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.110.985515","article-title":"Sex and race differences in right ventricular structure and function: The multi-ethnic study of atherosclerosis-right ventricle study","volume":"123","author":"Kawut","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2022.07.008_bib0148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: A systematic review","volume":"123","author":"Thiruvenkatarajan","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2022.07.008_bib0149","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"2","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1053\/j.jvca.2022.07.008_bib0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ejcts\/ezw326","article-title":"European association for cardiothoracic surgery expert consensus statement on the prevention and management of mediastinitis","volume":"51","author":"Abu-Omar","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2022.07.008_bib0151","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jtcvs.2016.01.060","article-title":"Prevention and management of sternal wound infections","volume":"152","author":"Lazar","year":"2016","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077022005225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077022005225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:00:06Z","timestamp":1760947206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077022005225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":151,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1053077022005225"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2022.07.008","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Evaluation and Care of Heart Transplant Candidates","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}